Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Not A Loophole? BIO Concerned About Limiting Orphan Designations For Pediatric Subsets of Common Diseases

Guidance word in red keyboard buttons

Related Content

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

May 16 2017

Orphan Designations For Pediatric Subgroups Of Common Diseases To End

Dec 19 2017

Pediatric Cancer Study Requirements Added To FDA User Fee Bill

Jul 12 2017

PDUFA VI: Pediatrics Group Seeks Earlier And Faster Studies

Mar 17 2017

Additional Topics

United States Rare Diseases Regulation FDA BioPharmaceutical

More from Rare Diseases

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window